89 related articles for article (PubMed ID: 19320648)
21. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
22. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
23. Limited utility of oral glucose tolerance test in biochemically active acromegaly.
Ribeiro-Oliveira A; Faje AT; Barkan AL
Eur J Endocrinol; 2011 Jan; 164(1):17-22. PubMed ID: 20926592
[TBL] [Abstract][Full Text] [Related]
24. Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly?
Dutta P; Korbonits M; Sachdeva N; Gupta P; Srinivasan A; Devgun JS; Bajaj A; Mukherjee KK
Neurol India; 2016; 64(2):252-8. PubMed ID: 26954802
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects.
Colao A; Pivonello R; Auriemma RS; Grasso LF; Galdiero M; Pivonello C; Lombardi G; Savastano S
Clin Endocrinol (Oxf); 2011 Feb; 74(2):234-40. PubMed ID: 21054474
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone after oral glucose overload: revision of reference values in normal subjects.
Rosário PW; Furtado MS
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1139-44. PubMed ID: 19082302
[TBL] [Abstract][Full Text] [Related]
27. Pitfalls in the diagnosis of acromegaly.
Pokrajac-Simeunovic A; Trainer PJ
Horm Res; 2004; 62 Suppl 3():74-8. PubMed ID: 15539804
[TBL] [Abstract][Full Text] [Related]
28. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly.
Grottoli S; Razzore P; Gaia D; Gasperi M; Giusti M; Colao A; Ciccarelli E; Gasco V; Martino E; Ghigo E; Camanni F
J Endocrinol Invest; 2003 Feb; 26(2):123-7. PubMed ID: 12739738
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of activity in postoperative acromegalics--plasma growth hormone levels during oral glucose tolerance test, daytime blood sampling and urinary GH excretion.
Hattori N; Shimatsu A; Tanoh T; Koshiyama H; Kato Y; Imura H
Endocrinol Jpn; 1990 Oct; 37(5):629-37. PubMed ID: 2128272
[TBL] [Abstract][Full Text] [Related]
30. Acromegaly symptoms without pituitary adenoma in an adolescent.
Güven A; Ozgen T; Belet U; Aydin M
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):945-9. PubMed ID: 17937067
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients.
Düğer H; Bostan H; Deryol HY; İmga NN; Uçan B; Çalapkulu M; Hepşen S; Akhanlı P; Gül Ü; Sencar ME; Çakal E; Özdemir Ş; Kızılgül M
Growth Horm IGF Res; 2022 Dec; 67():101501. PubMed ID: 36166917
[TBL] [Abstract][Full Text] [Related]
32. Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Monaghan PJ; Trainer PJ
Eur J Endocrinol; 2019 Nov; 181(5):C17-C20. PubMed ID: 31480015
[No Abstract] [Full Text] [Related]
33. Treatment of elderly acromegalics.
Arita K; Hirano H; Yunoue S; Fujio S; Tominaga A; Sakoguchi T; Sugiyama K; Kurisu K
Endocr J; 2008 Oct; 55(5):895-903. PubMed ID: 18552460
[TBL] [Abstract][Full Text] [Related]
34. Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls.
Markkanen H; Pekkarinen T; Välimäki MJ; Alfthan H; Kauppinen-Mäkelin R; Sane T; Stenman UH
Clin Chem; 2006 Mar; 52(3):468-73. PubMed ID: 16439607
[TBL] [Abstract][Full Text] [Related]
35. Biochemical monitoring of disease activity after surgery for acromegaly.
Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):492-4. PubMed ID: 14764750
[No Abstract] [Full Text] [Related]
36. Prevalence of Simple Renal Cysts in Acromegaly.
Yamamoto M; Matsumoto R; Fukuoka H; Iguchi G; Takahashi M; Nishizawa H; Suda K; Bando H; Takahashi Y
Intern Med; 2016; 55(13):1685-90. PubMed ID: 27374666
[TBL] [Abstract][Full Text] [Related]
37. [Acromegaly].
Matsuzaki T
Nihon Rinsho; 1969 Jul; 27(7):1916-7. PubMed ID: 4902407
[No Abstract] [Full Text] [Related]
38. Interassay differences in growth hormone measurement in acromegaly.
Barth JH; Smith JH; Clarkson P
Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():156-9. PubMed ID: 9133248
[TBL] [Abstract][Full Text] [Related]
39. Postoperative prognostic indicators of control of acromegaly.
Yamada S; Aiba T; Shishiba Y
Surg Neurol; 1989 Jan; 31(1):14-9. PubMed ID: 2645670
[TBL] [Abstract][Full Text] [Related]
40. Determinants of the growth hormone nadir during oral glucose tolerance test in adults.
Schilbach K; Gar C; Lechner A; Nicolay SS; Schwerdt L; Haenelt M; Dal J; Jørgensen JL; Störmann S; Schopohl J; Bidlingmaier M
Eur J Endocrinol; 2019 Jul; 181(1):55-67. PubMed ID: 31096183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
